Copyright
©The Author(s) 2026.
World J Orthop. Feb 18, 2026; 17(2): 112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757
Table 1 Medical comorbidities in the prosthetic joint infection cases
| Comorbidities | Cases |
| Diabetes mellitus | 10 |
| Heart failure | 9 |
| Chronic kidney disease | 8 |
| Hypothyroidism | 4 |
| Dementia | 3 |
| Epilepsy | 3 |
| Lymphoma | 1 |
Table 2 Results for each patient’s group, n (%)
| Measurement period | 2007 to June 15, 2019 | After June 15, 2019 | P value (two-tailed z test) |
| Total number of hemiarthroplasty cases | 1517 | 937 | |
| Number of cemented stem cases | 1086 (71.58) | 692 (73.8) | P = 0.2; z = -1.2 at a 95% confidence interval |
| Number of active smokers at the time of HA surgery | 62 (4.09) | 46 (4.9) | P = 0.33; z = -0.96 at a 95% confidence interval |
| Number of early PJI cases in the first 12 weeks | 19 (1.25) | 14 (1.49) | P = 0.6; z = -0.5 at a 95% confidence interval |
Table 3 Characteristics of the cases with early postoperative infection, n (%)/mean ± SD
| Measurement period | 2007 to June 15, 2019 (n = 19) | After June 15, 2019 (n = 14) | P value |
| Age (years) | 80.96 ± 12.1 | 78.6 ± 8.5 | P = 0.5 (NS, t test1) |
| BMI | 27.9 ± 7.1 | 25.6 ± 7 | P = 0.36 (NS, t test) |
| Diabetes mellitus | 4 (21) | 7 (50) | P = 0.136 (NS, Fisher’s exact test) |
| Chronic kidney disease | 5 (26.3) | 3 (21.4) | P = 1 (NS, Fisher’s exact test) |
| Time of presentation (weeks) | 5 ± 2.5 | 4.5 ± 2.6 | P = 0.58 (NS, t test) |
Table 4 Subgroup analysis after excluding the cases that died within 30 days post-op, n (%)
| Measurement period | 2007 to June 15, 2019 | After June 15, 2019 | P value (two-tailed z test) |
| Total number of hemiarthroplasty cases | 1395 | 894 | |
| Number of early PJIs in the first 12 weeks | 19 (1.36) | 14 (1.56) | P = 0.69; z = -0.4 at a 95% confidence interval |
| Number of diabetic cases | 43 (3.08) | 35 (3.91) | P = 0.28; z = -1 at a 95% confidence interval |
| Number of cases with BMI ≥ 30 | 225 (16.12) | 160 (17.89) | P = 0.27; z = -1 at a 95% confidence interval |
- Citation: Nageeb Mahmoud AM, Maniar HH, Bernate J, Horwitz DS. Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections. World J Orthop 2026; 17(2): 112757
- URL: https://www.wjgnet.com/2218-5836/full/v17/i2/112757.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i2.112757
